Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT01897714Phase 2Terminated
- Sponsor
- Oncopeptides AB
- Start
- Jul 2013
- Primary completion
- Dec 2017
- Countries
- 5
01
Overview
A Phase 2 trial of melphalan flufenamide in multiple myeloma (MM), sponsored by Oncopeptides AB. Started Jul 2013; status: terminated.
02
Drugs
melphalan flufenamide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01897714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01897714.